An interventional study of Seated rest and Exercise at moderate intensity in Healthy Adults and Adults With Stress-related Symptoms, sponsored by The Swedish School of Sport and Health Sciences. Completed at 1 site in Sweden. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-02.
Sponsored by The Swedish School of Sport and Health Sciences · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study aims to examine the role of exercise intensity in the acute effects of a single bout of aerobic exercise on neurotrophic factors, biomarkers of stress and inflammation, working memory task-related changes in prefrontal cortex oxygenation in adults with sub-clinical levels of stress-related symptoms.
This study initially set out to include 43 adult (20 - 40 years) participants experiencing stress-related symptoms and 43 healthy controls, matched by age, sex, and fitness. These procedures were approved by the Swedish Ethical Review Autority (Approval number 2022-07297-01 and 2023-08181-02). Due to recruitment difficulties the design was later changed to include all individuals with sub-clinical stress symptoms and using stress as a covariate instead of comparing groups of healthy and stressed individuals (Ethical review approval number 2025-01786-02). This is a randomized-order crossover experimental trial with three experimental conditions separated by a wash-out period of 7 days: 20-min leg cycling exercise at moderate intensity, 20-min leg cycling exercise at vigorous intensity, and 20-min seated rest (passive control condition).
Prior to entering the study, study inclusion/exclusion criteria will be controlled using digital screening. Before the experimental sessions, all participants will complete two introductory study visits. At the first introductory visit, the participant's maximal oxygen uptake (VO2max) will be determined using a fitness test. This information will be used to determine the individual workloads (% of individual VO2max) that the participant will be cycling at during the experimental session. At the second introductory visit, participants will complete a familiarization session, in which key methodological aspects of the study will be introduced to participants. Participants' augmentation index, as a measure of arterial stiffness, will also be completed during this visit.
In each of the three experimental sessions, participants will perform a computerized working memory task (n-back task) pre- and post-exercise (or seated rest). During the working memory task, functional near-infrared spectroscopy (fNIRS) will be used to measure task-related changes in prefrontal cortex oxygenation. As such, each participant will complete six fNIRS measurements, two measurements (pre, post) for each of the three experimental sessions (moderate, high, control). Simultaneous with the fNIRS measurements, blood flow velocity in the left and right middle cerebral artery will be assessed during the n-back tasks using Transcranial Doppler ultrasound. At each experimental session, blood will also be sampled from the antecubital vein at six time points: pre the first n-back task, pre and post the cycling exercise (or seated rest), pre and post the second n-back task, and post the final 10-min seated rest. Whole blood samples will be assessed for blood gases, acid-base status, electrolytes, hematocrit level, platelet count, and glucose. The separated blood plasma and serum samples will be used for measurements of neurotrophic factors, lactate, biomarkers of stress and inflammation, and factors involved in blood glucose control. Blood samples will also be used for targeted DNA screening for alleles of the BDNF.
Additionally, the participant's current mood, mental and physical fatigue, heart rate variability (HRV) and blood pressure will be assessed during four 10-min seated rest periods: pre and post n-back, and pre and post cycling exercise (or seated rest). Prior to each experimental study session, participants will have assessments of sleep quality the night before, current health status, physical activity level during the week prior to the test day, sleepiness level the last 10 min, and current mood. Participant's sleep quality and heart rate variability during the night before and after each experimental session will also be assessed.
A release of an updated version of this study was attempted prior to completion of the study on October 3 2025, but due to a shutdown of the US goverment this was not possible to register until in November 24 2025.
180 studies on the registry are indexed under Neuroinflammatory Diseases; 81 are open to participants now.
This study's enrollment of 24 is below the median of 44 across 113 interventional studies indexed under Neuroinflammatory Diseases.
Browse Neuroinflammatory Diseases studies →The Swedish School of Sport and Health Sciences is the lead sponsor of 12 studies on the registry; 5 are open to participants now.
Compared within Neuroinflammatory Diseases, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Participants experiencing sub-clinical levels of stress-related symptoms:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will be resting while seated on a comfortable chair for 20 minutes
Behavioral: Seated rest
Participants will perform a 20-min leg cycling exercise on a cycle ergometer at moderate intensity (60% of VO2max)
Behavioral: Exercise at moderate intensity
Participants will perform a 20-min leg cycling exercise on a cycle ergometer at vigorous intensity (80% of VO2max)
Behavioral: Exercise at vigorous intensity
Participants will be resting while seated on a comfortable chair for 20 minutes
Participants will perform a 20-min leg cycling exercise on a cycle ergometer at moderate intensity (60% of VO2max)
Participants will perform a 20-min leg cycling exercise on a cycle ergometer at vigorous intensity (80% of VO2max)
Changes in cerebral blood flow in prefrontal cortex
working memory task-related changes in prefrontal cortex oxygenation measured using functional near-infrared spectroscopy
Time frame: from before to after 20 minutes of exercise or seated rest
Brain-derived neurotrophic factor
pro and mature BDNF in blood sample taken from the forearm antecubital vein; concentrations measured in blood plasma and serum
Time frame: At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Working memory performance
computerized working memory task (n-back: 1-, 2- and 3-back)
Time frame: At one time point before and one time point after 20 minutes of exercise or seated rest (In total over 1 hour)
DNA allele of brain-derived neurotrophic factor
in blood sample taken before intervention from the forearm antecubital vein
Time frame: At one time point at baseline
Platelet count
in blood sample taken from the forearm antecubital vein
Time frame: At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Cortisol
biomarker of stress; in blood sample taken from the forearm antecubital vein
Time frame: At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Epinephrine
biomarker of stress; in blood sample taken from the forearm antecubital vein
Time frame: At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Norepinephrine
biomarker of stress; in blood sample taken from the forearm antecubital vein
Time frame: At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
C-reactive protein (CRP)
as a measure of systemic inflammation; in blood sample taken from the forearm antecubital vein
Time frame: At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Interleukin 6 (IL-6)
as a measure of systemic inflammation; in blood sample taken from the forearm antecubital vein
Time frame: At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Tumor necrosis factor alpha (TNF-α)
as a measure of systemic inflammation; in blood sample taken from the forearm antecubital vein
Time frame: At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Mood
measured with a short version of Positive and Negative Affect Schedule (PANAS-SF) that include 5 positive and 5 negative affect states; the scoring scale is from 1 (very slightly or not at all) to 5 (extremely)
Time frame: At two time points before and two time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Mental fatigue
measured using Visual Analogue Scale (VAS-F); scoring scale: a line with 100 mm in length with scores falling between 0 mm (extremely alert) and 100 mm (extremely tired)
Time frame: At two time points before and two time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Physical fatigue
measured using Borg Rating of Perceived Exertion scale; scoring scale: from 6 (no exertion) to 20 (maximal exertion)
Time frame: At two time points before and two time points after 20 minutes of exercise or seated rest (In total over 2 hours)
Sleep quality
measured using a Single-Item Sleep Quality Scale; scoring scale is from 0 (terrible) to 10 (excellent)
Time frame: Over the night before and the night after each experimental session (In total over 36 hours)
Sleepiness
measured using Karolinska Sleepiness Scale; scoring scale is from 1 (extremely alert) to 9 (extremely sleepy)
Time frame: At single time point before 20 minutes of exercise or seated rest
Heart rate variability
as an additional indicator of stress-related symptoms; measured with heart rate sensor and monitor
Time frame: Over the night before and the night after each experimental session (In total over 36 hours)
Augmentation index
as a measure of arterial stiffness and indicator of cardiovascular health
Time frame: At a single time point at baseline
Plan to share: No — There is no current plan to make individual participant data available to other researchers.
No publications or documents are linked to this record.
Ran from Feb 2024 to primary completion in Oct 2025, 19 months.
Of 35 interventional studies with no phase under Neuroinflammatory Diseases, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 44. This study's 19 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Swedish School of Sport and Health Sciences